SOX2 and glioblastoma: In this study, we demonstrate that elevation of SOX2 levels ∼2-fold in U87 and U118 glioblastoma cells leads to significant reductions in cellular proliferation by ∼65% (Figure 1) and ∼55% (Figure S1), respectively.